Effect of buspirone on thermal sensory and pain thresholds in human volunteers

Besson JM, Chaouch A: Peripheral and spinal mechanisms of nociception. Physiol Rev. 1987, 67 (1): 67-186.

Colpaert FC, Tarayre JP, Koek W, Pauwels PJ, Bardin L, Xu XJ, Wiesenfeld-Hallin Z, Cosi C, Carilla-Durand E, Assie MB, et al: Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia. Neuropharmacology. 2002, 43 (6): 945-958. 10.1016/S0028-3908(02)00119-3.

Palm F, Mossner R, Chen Y, He L, Gerlach M, Bischofs S, Riederer P, Lesch KP, Sommer C: Reduced thermal hyperalgesia and enhanced peripheral nerve injury after hind paw inflammation in mice lacking the serotonin-transporter. Eur J Pain. 2008, 12 (6): 790-797. 10.1016/j.ejpain.2007.11.009.

Kayser V, Elfassi IE, Aubel B, Melfort M, Julius D, Gingrich JA, Hamon M, Bourgoin S: Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A-/-, 5-HT1B-/-, 5-HT2A-/-, 5-HT3A-/- and 5-HTT-/- knock-out male mice. Pain. 2007, 130 (3): 235-248. 10.1016/j.pain.2006.11.015.

Fasmer OB, Berge OG, Post C, Hole K: Effects of the putative 5-HT1A receptor agonist 8-OH-2-(di-n-propylamino)tetralin on nociceptive sensitivity in mice. Pharmacol Biochem Behav. 1986, 25 (4): 883-888. 10.1016/0091-3057(86)90402-8.

Galeotti N, Ghelardini C, Bartolini A: 5-HT1A agonists induce central cholinergic antinociception. Pharmacology, biochemistry, and behavior. 1997, 57 (4): 835-841. 10.1016/S0091-3057(96)00401-7.

Kiss I, Degryse AD, Bardin L, Gomez de Segura IA, Colpaert FC: The novel analgesic, F 13640, produces intra- and postoperative analgesia in a rat model of surgical pain. Eur J Pharmacol. 2005, 523 (1–3): 29-39. 10.1016/j.ejphar.2005.09.003.

Holden JE, Farah EN, Jeong Y: Stimulation of the lateral hypothalamus produces antinociception mediated by 5-HT1A, 5-HT1B and 5-HT3 receptors in the rat spinal cord dorsal horn. Neuroscience. 2005, 135 (4): 1255-1268. 10.1016/j.neuroscience.2005.07.023.

Belcheva S, Petkov VD, Konstantinova E, Petkov VV, Boyanova E: Effects on nociception of the Ca2+ and 5-HT antagonist dotarizine and other 5-HT receptor agonists and antagonists. Acta Physiol Pharmacol Bulg. 1995, 21 (4): 93-98.

Murphy AZ, Murphy RM, Zemlan FP: Role of spinal serotonin1 receptor subtypes in thermally and mechanically elicited nociceptive reflexes. Psychopharmacology (Berl). 1992, 108 (1–2): 123-130. 10.1007/BF02245296.

Taiwo YO, Levine JD: Serotonin is a directly-acting hyperalgesic agent in the rat. Neuroscience. 1992, 48 (2): 485-490. 10.1016/0306-4522(92)90508-Y.

Berrocoso E, Rojas-Corrales MO, Mico JA: Differential role of 5-HT1A and 5-HT1B receptors on the antinociceptive and antidepressant effect of tramadol in mice. Psychopharmacology (Berl). 2006, 188 (1): 111-118. 10.1007/s00213-006-0464-6.

Berrocoso E, Mico JA: Role of serotonin 5-HT1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice. Int J Neuropsychopharmacol. 2009, 12 (1): 61-71. 10.1017/S1461145708008766.

Millan MJ, Colpaert FC: Attenuation of opioid induced antinociception by 5-HT1A partial agonists in the rat. Neuropharmacology. 1990, 29 (3): 315-318. 10.1016/0028-3908(90)90020-R.

Hoyer D, Pazos A, Probst A, Palacios JM: Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res. 1986, 376 (1): 85-96. 10.1016/0006-8993(86)90902-9.

Martikainen IK, Hirvonen J, Kajander J, Hagelberg N, Mansikka H, Nagren K, Hietala J, Pertovaara A: Correlation of human cold pressor pain responses with 5-HT(1A) receptor binding in the brain. Brain Res. 2007, 1172: 21-31. 10.1016/j.brainres.2007.07.036.

Kishore-Kumar R, Schafer SC, Lawlor BA, Murphy DL, Max MB: Single doses of the serotonin agonists buspirone and m-chlorophenylpiperazine do not relieve neuropathic pain. Pain. 1989, 37 (2): 223-227. 10.1016/0304-3959(89)90134-6.

Ramsay MA, Savege TM, Simpson BR, Goodwin R: Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974, 2 (5920): 656-659. 10.1136/bmj.2.5920.656.

Hurley RW, Adams MC: Sex, gender, and pain: an overview of a complex field. Anesth Analg. 2008, 107 (1): 309-317. 10.1213/01.ane.0b013e31816ba437.

Wiesenfeld-Hallin Z: Sex differences in pain perception. Gend Med. 2005, 2 (3): 137-145. 10.1016/S1550-8579(05)80042-7.

Rhudy JL, Williams AE: Gender differences in pain: do emotions play a role?. Gend Med. 2005, 2 (4): 208-226. 10.1016/S1550-8579(05)80051-8.

Levine FM, De Simone LL: The effects of experimenter gender on pain report in male and female subjects. Pain. 1991, 44 (1): 69-72. 10.1016/0304-3959(91)90149-R.

Mico JA, Berrocoso E, Ortega-Alvaro A, Gibert-Rahola J, Rojas-Corrales MO: The role of 5-HT1A receptors in research strategy for extensive pain treatment. Curr Top Med Chem. 2006, 6 (18): 1997-2003. 10.2174/156802606778522195.

Bardin L, Assie MB, Pelissou M, Royer-Urios I, Newman-Tancredi A, Ribet JP, Sautel F, Koek W, Colpaert FC: Dual, hyperalgesic, and analgesic effects of the high-efficacy 5-hydroxytryptamine 1A (5-HT1A) agonist F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-am ino]-methyl}piperidin-1-yl]methanone, fumaric acid salt]: relationship with 5-HT1A receptor occupancy and kinetic parameters. J Pharmacol Exp Ther. 2005, 312 (3): 1034-1042. 10.1124/jpet.104.077669.

Roca-Vinardell A, Ortega-Alvaro A, Gibert-Rahola J, Mico JA: The role of 5-HT1A/B autoreceptors in the antinociceptive effect of systemic administration of acetaminophen. Anesthesiology. 2003, 98 (3): 741-747. 10.1097/00000542-200303000-00025.

Gammans RE, Mayol RF, LaBudde JA: Metabolism and disposition of buspirone. Am J Med. 1986, 80 (3B): 41-51. 10.1016/0002-9343(86)90331-1.